GlobalData analyst Shehroz Mahmood notes that Novo Nordisk's amycretin could become the "next frontier" in obesity and T2D.

While the Phase III results confirm prior analyst sentiments, a KOL notes that GLP-1RAs could still show potential in the ...

Contineum Therapeutics’ M1 antagonist, PIPE-307, has failed to meet its primary and secondary efficacy endpoints in a Phase II trial in RRMS. Image credit: Andrzej Rostek via ShutterStock.com.

Nuvalent will discuss the data for TKI pre-treated ALK-positive NSCLC patients with the FDA in a pre-NDA meeting ...

The potential of digital twin technology is growing within the clinical trials landscape. Image credit: Gorodenkoff via ShutterStock.com. In recent years, automation and artificial intelligence (AI) ...

AbbVie’s star immunology asset, Rinvoq, has posted two more Phase III wins – this time in non-segmental vitiligo (NSV). Image credit: Doralin Samuel Tunas via Shutterstock.com. AbbVie may see its star ...

Part one will enrol around 100 subjects with at least one food allergy: egg, milk, peanut, cashew or walnut. Credit: Chokniti-Studio / Shutterstock.com. RAPT Therapeutics has commenced the prestIgE ...

Johnson & Johnson’s targeted therapeutic combination, Tecvayli-Darzalex Faspro, performed better than investigator’s choice standard of care in a Phase III trial recruiting patients with R/R multiple ...

Japanese pharmaceutical company Takeda has withdrawn itself from the cell therapy space amid its efforts to prioritise its portfolio. Image credit: Anusorn Nakdee via ShutterStock.com. Japanese pharma ...

The proposed clinical trials are expected to address evidence gaps and involve individuals and communities in their design. Credit: Ihar Halavach / Shutterstock.com. Major medical research funders are ...

Data presented at the AACR Special Conference in Cancer Research: Advances in Ovarian Cancer Research meeting suggest that Imunon’s IL-12 gene therapy IMNN-001 has been shown to work on innate and ...

During the initial part of the study, 22 subjects were administered daily doses of sonrotoclax, either 160mg or 320mg. Credit: Volha_R / Shutterstock.com. BeOne Medicines has shared encouraging ...